Reducing the Risk of Developing Major Depression in Adolescents/Young Adults With Minor Depression/Depression Symptoms
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00145951|
Recruitment Status : Terminated (Lost funding)
First Posted : September 5, 2005
Last Update Posted : March 28, 2014
The purpose of this research study is to assess the feasibility of a combined primary care/web-based depression prevention intervention. Primary care physicians (PCP) currently lack an alternative behaviorally-based approach to antidepressant medications for individuals with depression symptoms or minor depression, but who have not yet developed Major Depression.
The objective of this study is to compare the feasibility and efficacy of motivational interviewing (MI) versus brief advice in primary care to engage adolescents with a web-based depression prevention intervention.
|Condition or disease||Intervention/treatment|
|Depression||Behavioral: motivational interviewing, brief advice in primary care|
|Study Type :||Observational|
|Actual Enrollment :||93 participants|
|Official Title:||Randomized Trial of a Motivational Interview Versus Brief Advice in Primary Care to Engage Mid-Late Adolescents With a Web-based Depression Prevention Intervention|
|Study Start Date :||May 2006|
|Actual Primary Completion Date :||September 2007|
|Actual Study Completion Date :||December 2011|
Behavioral: motivational interviewing, brief advice in primary care
motivational interviewing, brief advice in primary care
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00145951
|United States, Illinois|
|University of Chicago|
|Chicago, Illinois, United States, 60637|
|Principal Investigator:||Benjamin Van Voorhees, MD||University of Chicago|